|
1
|
Tao ZQ, Shi AM, Wang KX and Zhang WD:
Epidemiology of prostate cancer: Current status. Eur Rev Med
Pharmacol Sci. 19:805–812. 2015.PubMed/NCBI
|
|
2
|
Debebe Z and Rathmell WK: Ror2 as a
therapeutic target in cancer. Pharmacol Ther. 150:143–148. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu X, Fortin K and Mourelatos Z:
MicroRNAs: Biogenesis and molecular functions. Brain Pathol.
18:113–121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao N, Lin T, Zhao C, Zhao S, Zhou S and
Li Y: MicroRNA-588 is upregulated in human prostate cancer with
prognostic and functional implications. J Cell Biochem. Oct 5.
2017, (Epub ahead of print). View Article : Google Scholar
|
|
6
|
Zhou YJ, Yang HQ, Xia W, Cui L, Xu RF, Lu
H, Xue Z, Zhang B, Tian ZN, Cao YJ, et al: Down-regulation of
miR-605 promotes the proliferation and invasion of prostate cancer
cells by up-regulating EN2. Life Sci. 190:7–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song XL, Tang Y, Lei XH, Zhao SC and Wu
ZQ: miR-618 inhibits prostate cancer migration and invasion by
targeting FOXP2. J Cancer. 8:2501–2510. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luo B, Kang N, Chen Y, Liu L and Zhang Y:
Oncogene miR-106a promotes proliferation and metastasis of prostate
cancer cells by directly targeting PTEN in vivo and in vitro.
Minerva Med. 109:24–30. 2018.PubMed/NCBI
|
|
9
|
Qu F, Zheng J, Gan W, Lian H, He H, Li W,
Yuan T, Yang Y, Li X, Ji C, et al: MiR-199a-3p suppresses
proliferation and invasion of prostate cancer cells by targeting
Smad1. Oncotarget. 8:52465–52473. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang ZG, Ma XD, He ZH and Guo YX:
miR-483-5p promotes prostate cancer cell proliferation and invasion
by targeting RBM5. Int Braz J Urol. 43:1060–1067. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pang H and Yue X: MiR-205 serves as a
prognostic factor and suppresses proliferation and invasion by
targeting insulin-like growth factor receptor 1 in human cervical
cancer. Tumour Biol. 39:10104283177013082017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Duan B, Guo T, Sun H, Cai R, Rui Q and Xi
Z: miR-205 as a biological marker in non-small cell lung cancer.
Biomed Pharmacother. 91:823–830. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Verdoodt B, Neid M, Vogt M, Kuhn V,
Liffers ST, Palisaar RJ, Noldus J, Tannapfel A and
Mirmohammadsadegh A: MicroRNA-205, a novel regulator of the
anti-apoptotic protein Bcl2, is downregulated in prostate cancer.
Int J Oncol. 43:307–314. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pazos MC, Abramovich D, Bechis A,
Accialini P, Parborell F, Tesone M and Irusta G: Gamma secretase
inhibitor impairs epithelial-to-mesenchymal transition induced by
TGF-β in ovarian tumor cell lines. Mol Cell Endocrinol.
440:125–137. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang R, Zhang C, Liu G, Gu R and Wu H:
MicroRNA-126 inhibits proliferation, migration, invasion and EMT in
osteosarcoma by targeting ZEB1. J Cell Biochem. 118:3765–3774.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu Y, Xie H, Liu Y, Liu W, Liu M and Tang
H: miR-484 suppresses proliferation and epithelial-mesenchymal
transition by targeting ZEB1 and SMAD2 in cervical cancer cells.
Cancer Cell Int. 17:362017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cha YJ, Lee JH, Han HH, Kim BG, Kang S,
Choi YD and Cho NH: MicroRNA alteration and putative target genes
in high-grade prostatic intraepithelial neoplasia and prostate
cancer: STAT3 and ZEB1 are upregulated during prostate
carcinogenesis. Prostate. 76:937–947. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun X, Li Y, Yu J, Pei H, Luo P and Zhang
J: miR-128 modulates chemosensitivity and invasion of prostate
cancer cells through targeting ZEB1. Jpn J Clin Oncol. 45:474–482.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Volinia S, Visone R, Galasso M, Rossi E
and Croce CM: Identification of microRNA activity by Targets'
Reverse EXpression. Bioinformatics. 26:91–97. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wei J, Zhang L, Li J, Zhu S, Tai M, Mason
CW, Chapman JA, Reynolds EA, Weiner CP and Zhou HH: MicroRNA-205
promotes cell invasion by repressing TCF21 in human ovarian cancer.
J Ovarian Res. 10:332017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niu K, Shen W, Zhang Y, Zhao Y and Lu Y:
MiR-205 promotes motility of ovarian cancer cells via targeting
ZEB1. Gene. 574:330–336. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang C, Long F, Wan J, Hu Y and He H:
MicroRNA-205 acts as a tumor suppressor in osteosarcoma via
targeting RUNX2. Oncol Rep. 35:3275–3284. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen S, Jin L, Nie S, Han L, Lu N and Zhou
Y: MiR-205 inhibits growth and invasion of neuroblastoma by
targeting cAMP responsive element binding protein 1. Oncol Res. Jun
26. 2017, (Epub ahead of print). View Article : Google Scholar
|
|
25
|
Zhuo Z and Yu H: miR-205 inhibits cell
growth by targeting AKT-mTOR signaling in progesterone-resistant
endometrial cancer Ishikawa cells. Oncotarget. 8:28042–28051. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nie G, Duan H, Li X, Yu Z, Luo L, Lu R, Ji
Z and Zhang W: MicroRNA-205 promotes the tumorigenesis of
nasopharyngeal carcinoma through targeting tumor protein
p53-inducible nuclear protein 1. Mol Med Rep. 12:5715–5722. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dou J, He X, Liu Y, Wang Y, Zhao F, Wang
X, Chen D, Shi F and Wang J: Effect of downregulation of ZEB1 on
vimentin expression, tumour migration and tumourigenicity of
melanoma B16F10 cells and CSCs. Cell Biol Int. 38:452–461. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Yan S, Liu X, Zhang W, Li Y, Dong
R, Zhang Q, Yang Q, Yuan C, Shen K, et al: miR-1236-3p represses
the cell migration and invasion abilities by targeting ZEB1 in
high-grade serous ovarian carcinoma. Oncol Rep. 31:1905–1910. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma J, Zhan Y, Xu Z, Li Y, Luo A, Ding F,
Cao X, Chen H and Liu Z: ZEB1 induced miR-99b/let-7e/miR-125a
cluster promotes invasion and metastasis in esophageal squamous
cell carcinoma. Cancer Lett. 398:37–45. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng Y, Luan F, Zeng L, Zhang Y and Ma K:
MiR-429 suppresses the progression and metastasis of osteosarcoma
by targeting ZEB1. EXCLI J. 16:618–627. 2017.PubMed/NCBI
|
